DARE · Company research
Dare Bioscience, Inc. Common Stock (DARE): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 0.79 | $10,754,159.32 | -7765624.6825 | 1.0741666666666667 | — | — | 70.5398925420615919 | 14.6424462864098490 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.